A144510 Stock Overview
GC Cell Corporation develops cell therapy products.
GC Cell Corporation Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₩47,000.00|
|52 Week High||₩125,800.00|
|52 Week Low||₩46,450.00|
|1 Month Change||-20.07%|
|3 Month Change||-14.23%|
|1 Year Change||-49.95%|
|3 Year Change||43.95%|
|5 Year Change||100.00%|
|Change since IPO||-2.29%|
Recent News & Updates
We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative
When companies post strong earnings, the stock generally performs well, just like Green Cross Lab Cell Corporation's...
We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
|A144510||KR Biotechs||KR Market|
Return vs Industry: A144510 exceeded the KR Biotechs industry which returned -51.9% over the past year.
Return vs Market: A144510 underperformed the KR Market which returned -29% over the past year.
|A144510 Average Weekly Movement||6.9%|
|Biotechs Industry Average Movement||7.3%|
|Market Average Movement||5.9%|
|10% most volatile stocks in KR Market||10.7%|
|10% least volatile stocks in KR Market||3.5%|
Stable Share Price: A144510 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: A144510's weekly volatility (7%) has been stable over the past year.
About the Company
GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in November 2021.
GC Cell Corporation Fundamentals Summary
|A144510 fundamental statistics|
Is A144510 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|A144510 income statement (TTM)|
|Cost of Revenue||₩133.16b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||3.51k|
|Net Profit Margin||20.96%|
How did A144510 perform over the long term?See historical performance and comparison